logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Z

Zhuoer Xie

h lee moffitt cancer center and research institute
H指数:20
被引数:3,555

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Early treatment failure after ciltacabtagene autoleucel in multiple myeloma with high-risk features: implications for risk-informed care

具有高危特征的多发性骨髓瘤在应用cilta-cabtagene autoleucel治疗后早期失败：对风险知情护理的启示

Blood Cancer Journal
IF11.6
2026-10-220
OAAI
Doris K. Hansen; Saurabh Zanwar; Lauren C. Peres; Danai Dima; Omar Castaneda Puglianini; Alicia Richards; Mahmoud R. Gaballa; Oren Pasvolsky; Aimaz Afrough; Brett M. Reid; Ariel Grajales-Cruz; Zhuoer Xie; Utkarsh Goel; Aishwarya Sannareddy; Christen M. Dillard; Christopher J. Ferreri; Shebli Atrash; Cindy Varga; Andrew J. Portuguese; Hitomi Hosoya; Lekha Mikkilineni; Nilesh Kalariya; Damian Mikulski; Charlotte B. Wagner; Christopher R. Cahoon; Peter Cheng; Christian A. Gordillo; Eli Zolotov; Evguenia Ouchveridze; Jeries Kort; Raffaella Cassano Cassano; Shonali Midha; James A. Davis; Rebecca Gonzalez; Megan M. Herr; Hamza Hassan; Sneha Purvey; Marcus J. Geer; Kimberly Green; Laura B. Oswald; Fabiana Perna; Hien D. Liu; Taiga Nishihori; Jack Khouri; Shahzad Raza; Faiz Anwer; Susan Bal; Omar Nadeem; Ciara L. Freeman; Rahul Banerjee; Leyla Shune; Ran Reshef; Kenneth H. Shain; Melissa Alsina; Rachid C. Baz; Douglas W. Sborov; Peter Voorhees; Larry D. Anderson; Luciano J. Costa; Noa Biran; Shaji K. Kumar; Frederick L. Locke; Yi Lin; Surbhi Sidana; Krina K. Patel
Bridging therapy response and type as determinants of cilta-cel outcomes in relapsed/refractory multiple myeloma

桥接疗法反应类型作为复发/难治性多发性骨髓瘤中cilta-cel疗效的预测因素

Blood Cancer Journal
IF11.6
2026-10-010
OA
Doris K. Hansen; Brett M. Reid; Ariel Grajales-Cruz; Peter Cheng; Zhuoer Xie; Brandon Blue; Dae Hyun Lee; Laura Oswald; Gabriel De Avila; David Scheiber-Camoretti; Ken Harada; Daniel De Avila; Brandon Kale; Karla Feliciano Salva; David Kaldas; Kristy Matte; Todd Stinard; Rebecca Gonzalez; Victoria Alegria; Matthew Perciavalle; Helen Pai; Mukta Sharma; Kevin C. De Braganca; Zaina P. Qureshi; Fabiana Perna; Hien Liu; Kenneth H. Shain; Rachid Baz; Taiga Nishihori; Melissa Alsina; Ciara L. Freeman; Omar Alexis Castaneda Puglianini; Frederick L. Locke; Lauren C. Peres
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS)

基于低甲基化制剂治疗的反应对高风险骨髓增生异常综合征/肿瘤患者生存结局的影响：考虑基线临床-分子风险和移植状态的国际骨髓增生异常综合征联盟(icMDS)分析

American Journal of Hematology
IF9.9
2026-08-280
PRE
Benjamin Rolles; Jan Philipp Bewersdorf; Tariq Kewan; Ondrej Blaha; Jessica M. Stempel; Luca Lanino; Najla H. Al Ali; Amy E. DeZern; Mikkael A. Sekeres; Geoffrey L. Uy; Samuel Urrutia; Hetty E. Carraway; Pinkal Desai; Elizabeth A. Griffiths; Eytan M. Stein; Andrew M. Brunner; Christine McMahon; Rory M. Shallis; Joshua F. Zeidner; Michael R. Savona; Shougat Barua; Namrata Sonia Chandhok; Constantine Logothetis; Aram Bidikian; Ted M. Getz; Gail J. Roboz; Eunice S. Wang; Amyah C. Harris; Maria L. Amaya; Hayley Hawkins; Somedeb Ball; Justin Grenet; Parisa Abedi; Shai Shimony; R. Coleman Lindsley; Zhuoer Xie; Yazan F. Madanat; Yasmin Abaza; Talha Badar; Torsten Haferlach; Jaroslaw P. Maciejewski; David Sallman; Anoop Enjeti; Kamal Al-Rabi; Khalid Halahleh; Devendra Hiwase; Maria Diez-Campelo; David Valcarcel; Claudia Haferlach; Lisa Pleyer; Ioannis Kotsianidis; Vasiliki Pappa; Valeria Santini; Angela Consagra; Aref Al-Kali; Seishi Ogawa; Yasuhito Nannya; Matteo Giovanni Della Porta; Rami S. Komrokji; Amer M. Zeidan; Maximilian Stahl
Real-world, multi-omics validation of the clinical relevance of molecular taxonomy for myelodysplastic syndromes (MDS)

多组学验证骨髓增生异常综合征(MDS)分子分类的临床相关性

HemaSphere
IF14.6
2026-07-280
OAAI
Giulia Maggioni; Gabriele Todisco; Elisabetta Sauta; Luca Lanino; Somedeb Ball; Jan P. Bewersdorf; Tariq Kewan; Najla H. Al Ali; Pierre Fenaux; Uwe Platzbecker; Valeria Santini; Zhuoer Xie; Andrew M. Brunner; Andrew T. Kuykendall; John M. Bennett; Rena Buckstein; Rafael Bejar; Hetty E. Carraway; Amy E. DeZern; Elizabeth A. Griffiths; Stephanie Halene; Robert P. Hasserjian; Alan F. List; Sanam Loghavi; Olatoyosi Odenike; Eric Padron; Mrinal M. Patnaik; Gail J. Roboz; Maximilian Stahl; Mikkael A. Sekeres; David P. Steensma; Michael R. Savona; Justin Taylor; Mina L. Xu; David A. Sallman; Stephen D. Nimer; Christopher S. Hourigan; Andrew H. Wei; Alessia Campagna; Marta Ubezio; Elena Riva; Denise Ventura; Nicole Pinocchio; Matteo Zampini; Alessandro Buizza; Antonio Russo; Francesco Pesce; Saverio D'Amico; Gianluca Asti; Mattia Delleani; Erica Travaglino; Cristina A. Tentori; Ivan Ferrari; Alessandra Crespi; Giulia Figini; Maria Di Matteo; Matteo Brindisi; Nicla Manes; Chiara Milanesi; Laura Crisafulli; Francesca Ficara; Gastone Castellani; Uma M. Borate; Fabio Efficace; Steven D. Gore; Tae K. Kim; Maria Diez-Campelo; Arjan A. van de Loosdrecht; Navel Daver; Maria Rozman; Alberto Orfao; Sa A. Wang; Kathryn Foucar; Marcelo Iastrebner; Phillip Scheinberg; Yasushi Miyazaki; Yazan F. Madanat; Aref Al-Kali; Moshe Mittelmann; Thomas Cluzeau; Lionel Ades; Ulrich Germing; Guillermo Garcia-Manero; Shahram Kordasti; Torsten Haferlach; Amer M. Zeidan; Rami S. Komrokji; Matteo G. Della Porta; An international study on behalf of GenoMed4all, Synthema, and icMDS consortia
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax—an analysis from the International Consortium for MDS (icMDS) VALIDATE database

高风险骨髓增生异常综合征/新生物患者接受去甲基化药物+维奈克拉治疗后的结局分析——国际骨髓增生异常综合征（icMDS）VALIDATE数据库分析

Blood Cancer Journal
IF11.6
2026-06-290
OAAI
Jan Philipp Bewersdorf; Tariq Kewan; Luca Lanino; Wei Wei; Tulika Rudra Gupta; Jessica M. Stempel; Najla H. Al Ali; Amy E. DeZern; Mikkael A. Sekeres; Geoffrey L. Uy; Samuel Urrutia; Hetty E. Carraway; Pinkal Desai; Elizabeth A. Griffiths; Eytan M. Stein; Andrew M. Brunner; Christine McMahon; Rory M. Shallis; Joshua F. Zeidner; Michael R. Savona; Hayley Hawkins; Namrata Sonia Chandhok; Constantine N. Logothetis; Aram Bidikian; Ted M. Getz; Gail J. Roboz; Benjamin Rolles; Eunice S. Wang; Amyah C. Harris; Maria L. Amaya; Somedeb Ball; Justin Grenet; Zhuoer Xie; Yazan F. Madanat; Yasmin Abaza; Talha Badar; Jaclynn Campos; Torsten Haferlach; Jaroslaw P. Maciejewski; David Sallman; Anoop Enjeti; Kamal Al-Rabi; Khalid Halahleh; Devendra Hiwase; Maria Diez-Campelo; David Valcarcel; Claudia Haferlach; Lisa Pleyer; Ioannis Kotsianidis; Vassiliki Pappa; Valeria Santini; Angela Consagra; Aref Al-Kali; Seishi Ogawa; Yasuhito Nannya; Maximilian Stahl; Matteo Giovanni Della Porta; Rami S. Komrokji; Amer M. Zeidan
Prognostic Score for Myelodysplastic Syndromes Based on Molecular Evolution

基于分子演化的骨髓增生异常综合征预后评分

NEJM Evidence
IF0
2026-05-262
PRE
Civettini, Ivan; Malighetti, Federica; Villa, Matteo; Crippa, Valentina; Aroldi, Andrea; Cavalca, Fabrizio; Graudenzi, Alex; Lanino, Luca; Maggioni, Giulia; Haferlach, Torsten; Fenaux, Pierre; Platzbecker, Uwe; Diez-Campelo, Maria; Borin, Lorenza Maria; Fumagalli, Monica; Zappaterra, Arianna; Manghisi, Beatrice; Al Ali, Najla H.; Sallman, David A.; Padron, Eric; Xie, Zhuoer; Chan, Onyee; Zeidan, Amer M.; Mologni, Luca; Piazza, Rocco; Komrokji, Rami S.; Della Porta, Matteo Giovanni; Gambacorti-Passerini, Carlo; Ramazzotti, Daniele
Multiple TET2 mutations confer additional survival benefit in both myelodysplastic and myeloproliferative chronic myelomonocytic leukemia subtypes

多个TET2突变在骨髓增生异常和骨髓增生性慢性粒单核细胞白血病亚型中均带来额外的生存益处

Leukemia
IF13.4
2025-06-240
PRE
Clifford M. Csizmar; Anuya Natu; Mark Gurney; Saubia Fathima; Ali Khalid A. Alsugair; Rashmi Kanagal-Shamanna; Sanam Loghavi; Alexandre Bazinet; Kelly Chien; Danielle Hammond; Courtney DiNardo; Tapan Kadia; Farhad Ravandi-Kashani; Naveen Pemmaraju; Koji Sasaki; Terra L. Lasho; Christy M. Finke; Aref Al-Kali; Hassan Alkhateeb; Kebede Begna; Naseema Gangat; Mehrdad Hefazi Torghabeh; Aasiya Matin; Abhishek A. Mangaonkar; Antoine N. Saliba; Ayalew Tefferi; Guillermo Garcia-Manero; Hagop M. Kantarjian; Rami S. Komrokji; Zhuoer Xie; Najla A. Ali; David Sallman; Eric Padron; Guillermo Montalban-Bravo; Mrinal M. Patnaik
Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/SyndromesdRecommendations From the International Consortium for Myelodysplastic Neoplasms/Syndromes (MDS [icMDS])

骨髓增生异常肿瘤/综合征的诊断和分类的当代方法国际骨髓增生异常肿瘤/综合征联合会 (MDS [icMDS]) 的建议

MODERN PATHOLOGY
IF5.5
2024-12-011
PRE
Aakash, Fnu; Gisriel, Savanah D.; Zeidan, Amer M.; Bennett, John M.; Bejar, Rafael; Bewersdorf, Jan Philipp; Borate, Uma M.; Boultwood, Jacqueline; Brunner, Andrew M.; Buckstein, Rena; Carraway, Hetty E.; Churpek, Jane E.; Daver, Naval G.; Dezern, Amy E.; Efficace, Fabio; Fenaux, Pierre; Figueroa, Maria E.; Garcia-Manero, Guillermo; Gore, Steven D.; Greenberg, Peter L.; Griffiths, Elizabeth A.; Halene, Stephanie; Hourigan, Christopher S.; Kim, Tae Kon; Kim, Nina; Komrokji, Rami S.; Kutchroo, Vijay K.; List, Alan F.; Little, Richard F.; Majeti, Ravindra; Nazha, Aziz; Nimer, Stephen D.; Odenike, Olatoyosi; Padron, Eric; Patnaik, Mrinal M.; Platzbecker, Uwe; Porta, Matteo G. Della; Roboz, Gail J.; Sallman, David A.; Santini, Valeria; Sanz, Guillermo; Savona, Michael R.; Sekeres, Mikkael A.; Stahl, Maximilian; Starczynowski, Daniel T.; Steensma, David P.; Taylor, Justin; Abdel-Wahab, Omar; Wei, Andrew H.; Xie, Zhuoer; Xu, Mina L.; Hasserjian, Robert P.; Loghavi, Sanam
Phase 1/1b Dose Escalation and Expansion of CPX-351 in Combination with Gemtuzumab Ozogamicin in Newly Diagnosed Acute Myeloid Leukemia

I期/II期剂量递增和扩展研究：CPX-351联合Gemtuzumab Ozogamicin治疗新诊断急性髓性白血病

BLOOD
IF23.1
2024-11-050
PRE
Chan, Onyee; Sweet, Kendra L.; Talati, Chetasi; Zahra, Fatima Tuz; Nardelli, Lisa Ann; Lamba, Jatinder K.; Kim, Jongphil; Song, Jinming; Xie, Zhuoer; Yun, Seongseok; Kuykendall, Andrew T.; Padron, Eric; Walker, Alison R.; Komrokji, Rami S.; Lancet, Jeffrey E.; Sallman, David
IDH-1 Somatic Mutations Are More Commonly Observed Among Patients with Concomitant Myelodysplastic Syndromes (MDS) and Autoimmune Rheumatoid Diseases (AIRD)

IDH-1体细胞突变在同时患有骨髓增生异常综合征（MDS）和自身免疫性风湿病（AIRD）的患者中更为常见。

BLOOD
IF23.1
2024-11-050
PRE
Komrokji, Rami S.; Al Ali, Najla H.; Xie, Zhuoer; Komrokji, Zena; Jabbour, Joseph E.; Chan, Onyee; Yun, Seongseok; Kuykendall, Andrew T.; Walker, Alison R.; Lancet, Jeffrey E.; Padron, Eric; Sallman, David
Prospective Evaluation of the Impact of Measurable Residual Disease (MRD) By Error Corrected Next-Generation Sequencing (NGS) with CPX-351 in Acute Myeloid Leukemia (AML)

CPX-351在急性髓系白血病(AML)中通过纠错型下一代测序(NGS)对可测量残留病灶(MRD)影响的展望性评估

BLOOD
IF23.1
2024-11-050
PRE
Sallman, David; Mclemore, Amy F.; Chan, Onyee; Kuykendall, Andrew T.; Padron, Eric; Xie, Zhuoer; Walker, Alison R.; Spencer, David H.; Komrokji, Rami S.; Lancet, Jeffrey E.; Jacoby, Meagan
Disparities in AML Survival in the Targeted Therapy Era: Real World Evidence of Enhanced Equity of Outcomes for Patients in Medically Underserved Areas

靶向治疗时代AML生存率的差异：医疗资源匮乏地区患者结局公平性提升的真实世界证据

BLOOD
IF23.1
2024-11-050
PRE
Zahra, Fatima Tuz; Ong, Faustine; Shahzad, Moazzam; Chan, Onyee; Al Ali, Najla H.; Lancet, Jeffrey E.; Walker, Alison R.; Sallman, David; Komrokji, Rami S.; Yun, Seongseok; Kuykendall, Andrew T.; Padron, Eric; Xie, Zhuoer

研究方向

暂未获取到该数据
R
Rami S. Komrokji
H 指数:68论文数:1,498被引数:1.8万
D
David A. Sallman
H 指数:46论文数:817被引数:9,080
E
Eric Padron
H 指数:53论文数:903被引数:1.5万
M
Mrinal M. Patnaik
H 指数:72论文数:1,243被引数:1.9万
A
Amer M. Zeidan
H 指数:56论文数:844被引数:1.1万
J
Jan Philipp Bewersdorf
H 指数:34论文数:268被引数:3,582
O
Onyee Chan
H 指数:19论文数:306被引数:1,800
M
Maximilian Stahl
H 指数:37论文数:288被引数:4,611
E
Elizabeth A. Griffiths
H 指数:49论文数:403被引数:1.0万
A
Amy E. DeZern
H 指数:57论文数:500被引数:1.0万